Structure-Activity-Based Design of a Synthetic Malaria Peptide Eliciting Sporozoite Inhibitory Antibodies in a Virosomal Formulation
- 29 May 2007
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 14 (5) , 577-587
- https://doi.org/10.1016/j.chembiol.2007.04.008
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Malaria: New Vaccines for Old?Cell, 2006
- Malaria vaccines 1985–2005: a full circle?Trends in Parasitology, 2005
- Malaria vaccines: Evaluation and implementationActa Tropica, 2005
- MalariaThe Lancet, 2005
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Vaccine-induced immunity to malaria parasites and the need for novel strategiesTrends in Parasitology, 2005
- Malaria vaccines: if at first you don't succeed…Trends in Parasitology, 2004
- Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trialThe Lancet, 2004
- Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuatedPlasmodium falciparumsporozoite vaccineJournal of Experimental Biology, 2003
- Induction of Parasite Growth-Inhibitory Antibodies by a Virosomal Formulation of a Peptidomimetic of Loop I from Domain III of Plasmodium falciparum Apical Membrane Antigen 1Infection and Immunity, 2003